Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Anaeropharma Makes Progress With US Clinical Trials of New Anti-Cancer Drug

Filed Under: Pharma Tagged With: , , , , , , , ,

Anaeropharma Science Inc., a venture originating at Shinshu University, is set to advance its development of Bifidobacterium-based anti-cancer drug APS001F…....

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Tokyo Tech Devises a New Generation of BPA for Use in Chemical Surgery
Tokyo Tech Devises a New Generation of BPA for Use in…
Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Coronavirus Report – Part 58: Clinical Trials Begin for Slew of Potential Vaccines
Coronavirus Report – Part 58: Clinical Trials Begin for Slew…
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in…
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Coronavirus Report – Part 47: Fujifilm Plans Major Increase to Avigan Production
Coronavirus Report – Part 47: Fujifilm Plans Major Increase…